MYL3 | Myosin, light chain 3, alkali; ventricular, skeletal, slow | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Group enriched |
PHKG1 | Phosphorylase kinase, gamma 1 (muscle) | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
TNNT1 | Troponin T type 1 (skeletal, slow) | Disease related genes
| | | | | Tissue enriched |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | | | | Group enriched |
PLCD4 | Phospholipase C, delta 4 | Enzymes
| | | | | Tissue enriched |
RTN2 | Reticulon 2 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
BIN1 | Bridging integrator 1 | Disease related genes
| | | | | Tissue enriched |
CAV3 | Caveolin 3 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
HHATL | Hedgehog acyltransferase-like | Predicted membrane proteins
| | | | | Group enriched |
MURC | Muscle-related coiled-coil protein | | | | | | Group enriched |
SH3BGR | SH3 domain binding glutamic acid-rich protein | | | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
TXLNB | Taxilin beta | | | | | | Group enriched |
C1orf167 | Chromosome 1 open reading frame 167 | | | | | | Group enriched |
CKM | Creatine kinase, muscle | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
NT5C1A | 5'-nucleotidase, cytosolic IA | Enzymes
| | | | | Group enriched |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
ACHE | Acetylcholinesterase (Yt blood group) | Blood group antigen proteins Enzymes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
CAMK2B | Calcium/calmodulin-dependent protein kinase II beta | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
CARNS1 | Carnosine synthase 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
MYO18A | Myosin XVIIIA | Cytoskeleton related proteins Plasma proteins
| | | | | Group enriched |
OBSCN | Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enriched |
PVALB | Parvalbumin | | | | | | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | | | | Group enriched |
SGCA | Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
SGCG | Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
SMYD1 | SET and MYND domain containing 1 | Enzymes
| | | | | Group enriched |
ADCK3 | AarF domain containing kinase 3 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Tissue enriched |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
KBTBD13 | Kelch repeat and BTB (POZ) domain containing 13 | Disease related genes
| | | | | Tissue enriched |
TPM3 | Tropomyosin 3 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ANK1 | Ankyrin 1, erythrocytic | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | Enzymes Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
CECR2 | Cat eye syndrome chromosome region, candidate 2 | | | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
EYA4 | Eyes absent homolog 4 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
FAM47E-STBD1 | FAM47E-STBD1 readthrough | Plasma proteins
| | | | | Tissue enhanced |
FLNC | Filamin C, gamma | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enhanced |
FNDC5 | Fibronectin type III domain containing 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
GPD1 | Glycerol-3-phosphate dehydrogenase 1 (soluble) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HSPB2-C11orf52 | HSPB2-C11orf52 readthrough (NMD candidate) | | | | | | Tissue enhanced |
HSPB6 | Heat shock protein, alpha-crystallin-related, B6 | | | | | | Tissue enhanced |
KCNQ5 | Potassium voltage-gated channel, KQT-like subfamily, member 5 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
LMCD1 | LIM and cysteine-rich domains 1 | | | | | | Tissue enhanced |